IL6 and Gliosis: Gliosis with increased production of potentially harmful inflammatory mediators, including interleukin 1β (IL1β), tumour necrosis factor α (TNFα), interleukin 6 (IL6), prostanoids, and reactive oxygen species (ROS), was reported in the spinal cords of ALS patients19.